Lisa Gray work email
- Valid
- Valid
- Valid
- Valid
- Valid
Lisa Gray personal email
- Valid
- Valid
- Valid
Lisa Gray phone numbers
Lisa is the CEO of Ilera Holistic Healthcare, which strives to improve the quality of life for patients by supplying consistent, effective, and safe medical marijuana solutions that provide relief and enhance wellness.Lisa is also a co-founder and Managing Partner of PIPV Capital, a fully integrated Buy-Out Private Equity Firm specializing in Life Sciences. Lisa’s experience spans business development, finance, marketing and operations. Lisa generates investments, acts as advisor, board member and/or CEO for portfolio companies. Lisa was previously Managing Director Life Sciences Quoin Capital and held various roles at GlaxoSmithKline and Coopers & Lybrand. Lisa is a CPA and has a BS Accountancy, MBA Finance and a Post-Graduate Degree in Marketing. Lisa is active with various non-profits and is a proud mother of two boys.
-
Chief Executive OfficerIlera Holistic Healthcare Jan 2023 - PresentIlera Holistic Healthcare strives to improve the quality of life for patients by supplying consistent, effective, and safe medical marijuana solutions that provide relief and enhance wellness. -
Co-Founder And Managing PartnerPipv Capital 2004 - PresentPIPV Capital (formerly Phoenix IP Ventures) is a Buy-Out Private Equity Firm looking to capitalize on the attractive fundamentals of the global healthcare industry. The firm seeks quality marketed products and technology platforms for acquisition and investment. Lisa’s experience spans business development, finance, marketing and operations. Lisa generates investments, acts as advisor, board member and/or CEO for portfolio companies. The firm has raised and deployed over $1BB in the life sciences on a global basis.
-
Board Director / Co-FounderZelira Therapeutics Dec 2019 - May 2023Perth, Western Australia, AuZelira Therapeutics Ltd is a leading global therapeutic medicinal cannabis company with access to the world’s largest and fastest growing cannabis markets. Zelira owns a portfolio of proprietary revenue generating products and a pipeline of candidates undergoing clinical development that are positioned to enter global markets from 2020. The company is focused on developing branded cannabis products for the treatment of a variety of medical conditions. Lisa was Co-founder and Vice Chair of Ilera Therapeutics LLC, acquired by Zelda Therapeutics also in 2019, which renamed itself Zelira Therapeutics. -
Evp Organizational DevelopmentTerrascend Oct 2020 - May 2021King Of Prussia, Pa, UsLisa is focused on the strategy/integration/BD/HR efforts of TerrAscend North East USA. -
Co-Founder, Vice Chair, Chief Financial OfficerIlera Healthcare/Terrascend Jun 2016 - Sep 2020Lisa was the founding Vice Chair and CFO driving the application for and establishment of Ilera Healthcare’s vertically integrated Grower, Processor and Dispenser Medicinal Marijuana licenses in Pennsylvania with our team. The company was acquired by TerrAscend in 2019.
-
Ceo And ChairGlycan Biosciences Llc 2012 - Dec 2018Lisa was Chairperson and former CEO for Glycan Biosciences LLC (a PIPV portfolio company) - Glycan is establishing the foundation for a new class of compounds (Glycanics) that address chronic inflammatory diseases by modulating the activity of multiple key inflammatory proteins. Glycan views chronic inflammatory diseases from a Systems Biology perspective that indicates multiple pathways and a diversity of proteins involved in switching from “alert” to “attack” mode.
-
Co-Founder And Board MemberIroko Pharmaceuticals 2007 - Mar 2016Iroko Pharmaceuticals is a global specialty pharmaceutical company focused on developing and commercializing innovative treatment options for responsible pain management, through a dynamic, collaborative approach—including the use of novel and proprietary technologies—Iroko develops and commercializes products that help patients manage their pain responsibly. Iroko’s goal is to deliver value to patients, health care professionals, and other stakeholders.
-
Co-Founder, Board Member, Evp Corporate DevelopmentIceutica 2005 - Mar 2016iCeutica works with pharmaceutical partners to create new branded medicines by combining our proprietary SoluMatrix™ Fine Particle Technology with our partners’ product experience and commercial insights. The resulting products provide meaningful clinical benefits for patients and have clearly defined pathways to regulatory and commercial success. There are numerous FDA approved and late-stage products in development that utilize our SoluMatrix technology.
-
Managing Director Life SciencesQuoin Capital 2006 - 2011Quoin provides personalized services to our institutional brokerage, government, project consulting and venture capital clients worldwide. -
Coo, Gsk VenturesGlaxosmithkline (Gsk) Research And Development 2000 - 2004Brentford, Middlesex, GbGSK is a science-led global healthcare company. GSK Ventures was the Intellectual Property-Based Venture Capital arm within GlaxoSmithKline's Research and Development Division. We established and built the team to create value from GSK's non-progressed development stage assets. Lisa, with her now partners Osagie Imasogie and Zoltan Kerekes, worked with this team to build the organization, the processes, the linkage with the cash-based venture capital community and to lead deal teams as well as ensure the organization's deal teams were on track and appropriately supported. The group did ~30 transactions, primarily 'asset for equity' investment transactions in small to mid sized companies, PIPES, spin-outs, and traditional licensing deals. -
VariousGlaxosmithkline (Gsk) Research And Development 1991 - 2000Brentford, Middlesex, Gb
-
Director, Hospital MarketingGlaxosmithkline (Gsk) Research And Development 1996 - 1997Brentford, Middlesex, GbLisa was the first marketing lead for this newly segmented Hospital Markets Group in SB's Clinical Labs Division (SBCL), where she was tasked with developing differentiated products for SBCL's hospital clients, leveraging the value proposition within the SBCL's informatics capabilities. Lisa implemented new programs with the national sales organization.
-
Group Director, Product Development StrategySmithkline Beecham R&D 1998 - 1999This team was tasked with bringing commercial insight into the product development process in GSK's Research and Development division. Team Members participated in therapeutic area executive teams to set strategy and budgets, define Target Product Profiles for development stage assets working with the scientific and clinical teams, and prepare product valuations to determine commercial potential/ranges of various assets. In addition, Lisa worked actively with the organization in defining valuation processes and metrics related to prioritizing discovery and development state opportunities.
-
Head Financial PlanningSmithkline Beecham R&D 1997 - 1998Lisa was responsible for establishing and managing the Global Business Partner organization that managed the worldwide R&D budgeting process, leading the implementation of the new IT platform and budgeting process for shifting the planning mindset from a departmental to a project costing approach, so the organization had transparency to the actual costs of each compound progressing through R&D. Lisa, reported to the CFO, with her team managing and monitoring the strategic and tactical planning processes for implementing the R&D division's ten year strategies into implementable three and one year tactical plans.
-
International Operations ConsultantSmithkline Beecham Corporate 1991 - 1995Lisa worked across divisions, including Pharmaceuticals, R&D, Clinical Laboratories, Consumer Healthcare, Informatics and Pharmacy Benefits Management conducting various business reviews, primarily internationally. These operational reviews included cash management, inventory management, internal controls reviews, marketing and sales processes, investigative reviews, and manufacturing reviews.
-
Auditor And ConsultantCoopers & Lybrand 1988 - 1991GbLisa started as an Auditor then shifted into Management Consulting working primarily on organizational design projects and activity-based costing projects across multiple industries including healthcare, aerospace, defense, real estate and manufacturing.
Lisa Gray Skills
Lisa Gray Education Details
-
Villanova UniversityAccountancy -
Penn State UniversityFinance
-
Widener UniversityMarketing Management
Frequently Asked Questions about Lisa Gray
What company does Lisa Gray work for?
Lisa Gray works for Ilera Holistic Healthcare
What is Lisa Gray's role at the current company?
Lisa Gray's current role is CEO Ilera Holistic Healthcare.
What is Lisa Gray's email address?
Lisa Gray's email address is li****@****ipv.com
What is Lisa Gray's direct phone number?
Lisa Gray's direct phone number is +161022*****
What schools did Lisa Gray attend?
Lisa Gray attended Villanova University, Penn State University, Widener University.
What are some of Lisa Gray's interests?
Lisa Gray has interest in Yoga, Ice Hockey, Karate, Coaching Youth Sports.
What skills is Lisa Gray known for?
Lisa Gray has skills like Strategic Financial Planning, Strategic Planning, Financial Analysis, Venture Capital, Fundraising, Change Management, Marketing, Team Building, Project Management, Mergers, Commercialization, Biotechnology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial